<p>HCA Healthcare（纽约证券交易所代码：HCA - 获取免费报告）在周二发布的报告中，摩根大通将其目标价从 535.00 美元下调至 490.00 美元，MarketScreener 报道。该券商目前对该股票给予 “中性” 评级。摩根大通的目标价意味着该股票相较于之前的收盘价有 20.76% 的潜在上涨空间。</p>
<p>获取 <strong>HCA Healthcare</strong> 的提醒：</p>
<ul>
<li>美国老龄化可能使 HCA Healthcare 成为长期赢家</li>
</ul>
<p>其他一些研究公司也对 HCA 发表了看法。Cantor Fitzgerald 在 3 月 4 日的研究报告中重申了对 HCA Healthcare 股票的 “增持” 评级。高盛集团在 1 月 28 日的报告中将 HCA Healthcare 的目标价从 520.00 美元上调至 558.00 美元，并给予该公司 “买入” 评级。Leerink Partners 在 4 月 27 日的研究报告中将 HCA Healthcare 的目标价从 573.00 美元下调至 500.00 美元，并对该公司给予 “跑赢大盘” 评级。华尔街 Zen 在 5 月 2 日的研究报告中将 HCA Healthcare 的评级从 “买入” 下调至 “持有”。最后，KeyCorp 在 4 月 27 日的报告中将 HCA Healthcare 的目标价从 550.00 美元下调至 510.00 美元，并对该股票给予 “增持” 评级。十六位研究分析师对该股票给予 “买入” 评级，七位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “适度买入”，平均目标价为 515.77 美元。</p>
<p><strong>查看我们关于 HCA 的最新报告</strong></p>
<h2>HCA Healthcare 股票表现</h2>
<ul>
<li>该 ETF 证明医疗保健反弹是真实的</li>
</ul>
<p>周二，纽约证券交易所 HCA 的交易价格下跌 17.02 美元，达到 405.77 美元。该公司的股票交易量为 245,089 股，而其平均交易量为 1,122,558 股。HCA Healthcare 的十二个月低点为 330.00 美元，十二个月高点为 556.52 美元。该公司的市值为 900.2 亿美元，市盈率为 14.04，市盈率/增长比率为 1.34，贝塔值为 1.18。该公司的 50 日移动平均价格为 476.49 美元，200 日移动平均价格为 485.66 美元。</p>
<p>HCA Healthcare（纽约证券交易所代码：HCA - 获取免费报告）最近在 4 月 24 日发布了季度财报。该公司报告每股收益（EPS）为 7.15 美元，低于共识预期的 7.19 美元（差额为 0.04 美元）。该公司在本季度的收入为 191.1 亿美元，而分析师预期为 190.9 亿美元。HCA Healthcare 的净利润率为 8.89%，股本回报率为负 295.93%。该公司的收入同比增长 4.3%。去年同期，该公司每股收益为 6.45 美元。HCA Healthcare 已将其 2026 财年的指导目标设定为 29.100-31.500 美元每股收益。作为一个整体，卖方分析师预测 HCA Healthcare 在当前财年将发布 30.07 美元每股收益。</p>
<h2>HCA Healthcare 的内部买卖</h2>
<ul>
<li>MarketBeat 周报 – 07/28 - 08/01</li>
</ul>
<p>在相关消息中，执行副总裁 Michael R. Mcalevey 在 2 月 18 日的交易中出售了 1,694 股公司的股票。该股票以平均价格 533.37 美元出售，总价值为 903,528.78 美元。出售后，该执行副总裁持有 8,853 股公司的股票，价值约为 4,721,924.61 美元。这代表其持股减少了 16.06%。该交易已在证券交易委员会的备案中披露，可以通过此链接访问。公司内部人士目前持有 1.50% 的股票。</p>
<h2>HCA Healthcare 的机构交易</h2>
<p>大型投资者最近对该股票的持仓进行了调整。国家养老服务在第三季度将其在 HCA Healthcare 的股份增加了 2.9%。国家养老服务目前持有 626,585 股公司股票，价值为 267,051,000 美元，此前在上个季度购买了 17,531 股。Savant Capital LLC 在第三季度将其在 HCA Healthcare 的股份增加了 37.7%。Savant Capital LLC 目前持有 4,548 股公司股票，价值为 1,938,000 美元，此前在上个季度增加了 1,246 股。Sector Gamma AS 在第三季度将其在 HCA Healthcare 的持仓增加了 36.0%。Sector Gamma AS 目前持有 10,883 股公司股票，价值为 4,638,000 美元，此前在上个季度增加了 2,883 股。Nordea Investment Management AB 在第四季度将其在 HCA Healthcare 的持仓增加了 11.2%。Nordea Investment Management AB 目前持有 1,084,590 股公司股票，价值为 507,393,000 美元，此前在上个季度购买了 108,849 股。最后，AlphaQuest LLC 在第三季度将其在 HCA Healthcare 的持仓增加了 2,855.2%。AlphaQuest LLC 目前持有 5,999 股公司股票，价值为 2,557,000 美元，此前在上个季度增加了 5,796 股。机构投资者和对冲基金持有该公司 62.73% 的股票。</p>
<h2>关于 HCA Healthcare</h2>
<p>（获取免费报告）</p>
<p>HCA Healthcare 是一家以盈利为目的的医疗设施运营商，总部位于田纳西州纳什维尔。该公司成立于 1968 年，拥有并运营一系列医院和相关医疗设施，并通过有机扩展和收购成长为大型住院和门诊服务提供商。</p>
<p>该公司的核心业务包括急性护理医院、独立外科和急救中心以及门诊诊所的运营。HCA 的服务涵盖住院护理、外科服务、急救医学、诊断影像和实验室检测，以及各种门诊和流动护理服务。</p>
<h2>推荐故事</h2>
<ul>
<li>我们更看好的五只股票比 HCA Healthcare 更好</li>
<li>重塑人工智能：NextEra Energy 引发了一场巨型合并</li>
<li>切换开关：福特会是下一个大能源股票吗？</li>
<li>纳米核能的新交易是否提升了前景？</li>
<li>3 只内部人士在 2026 年买入的股息股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 HCA Healthcare 吗？</h2>
<p>在考虑 HCA Healthcare 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 HCA Healthcare 并不在名单上。</p>
<p>虽然 HCA Healthcare 目前在分析师中有中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

HCA控股

标普全球医疗股指数 ETF - iShares

美国医疗保健供应商 ETF - iShares

标普医疗保健服务 ETF - SPDR

医疗业 ETF - SPDR

医疗业 ETF - Vanguard

<p>摩根大通已将 HCA Healthcare 的目标股价从 535.00 美元下调至 490.00 美元，维持 “中性” 评级。该股票目前的共识评级为 “适度买入”，平均目标价格为 515.77 美元。HCA 的股票交易价格下跌至 405.77 美元，市值为 900.2 亿美元。分析师预测本财年的每股收益为 30.07</p>

<p>HCA Healthcare (NYSE:HCA - Get Free Report) had its target price cut by research analysts at JPMorgan Chase &amp; Co. from $535.00 to $490.00 in a report issued on Tuesday,MarketScreener reports. The brokerage presently has a &#34;neutral&#34; rating on the stock. JPMorgan Chase &amp; Co.'s target price points to a potential upside of 20.76% from the stock's previous close.</p>
<div class="lb-trans"><p>HCA Healthcare（纽约证券交易所代码：HCA - 获取免费报告）在周二发布的报告中，摩根大通将其目标价从 535.00 美元下调至 490.00 美元，MarketScreener 报道。该券商目前对该股票给予 “中性” 评级。摩根大通的目标价意味着该股票相较于之前的收盘价有 20.76% 的潜在上涨空间。</p>
</div><p>Get <strong>HCA Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>HCA Healthcare</strong> 的提醒：</p>
</div><ul>
<li>The Aging of America Could Make HCA Healthcare a Long-Term Winner</li>
</ul>
<div class="lb-trans"><ul>
<li>美国老龄化可能使 HCA Healthcare 成为长期赢家</li>
</ul>
</div><p>A number of other research firms have also weighed in on HCA. Cantor Fitzgerald reiterated an &#34;overweight&#34; rating on shares of HCA Healthcare in a research report on Wednesday, March 4th. The Goldman Sachs Group lifted their target price on shares of HCA Healthcare from $520.00 to $558.00 and gave the company a &#34;buy&#34; rating in a report on Wednesday, January 28th. Leerink Partners reduced their price objective on shares of HCA Healthcare from $573.00 to $500.00 and set an &#34;outperform&#34; rating for the company in a research report on Monday, April 27th. Wall Street Zen downgraded HCA Healthcare from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research note on Saturday, May 2nd. Finally, KeyCorp dropped their price objective on HCA Healthcare from $550.00 to $510.00 and set an &#34;overweight&#34; rating on the stock in a report on Monday, April 27th. Sixteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $515.77.</p>
<div class="lb-trans"><p>其他一些研究公司也对 HCA 发表了看法。Cantor Fitzgerald 在 3 月 4 日的研究报告中重申了对 HCA Healthcare 股票的 “增持” 评级。高盛集团在 1 月 28 日的报告中将 HCA Healthcare 的目标价从 520.00 美元上调至 558.00 美元，并给予该公司 “买入” 评级。Leerink Partners 在 4 月 27 日的研究报告中将 HCA Healthcare 的目标价从 573.00 美元下调至 500.00 美元，并对该公司给予 “跑赢大盘” 评级。华尔街 Zen 在 5 月 2 日的研究报告中将 HCA Healthcare 的评级从 “买入” 下调至 “持有”。最后，KeyCorp 在 4 月 27 日的报告中将 HCA Healthcare 的目标价从 550.00 美元下调至 510.00 美元，并对该股票给予 “增持” 评级。十六位研究分析师对该股票给予 “买入” 评级，七位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “适度买入”，平均目标价为 515.77 美元。</p>
</div><p><strong>View Our Latest Report on HCA</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 HCA 的最新报告</strong></p>
</div><h2>HCA Healthcare Stock Performance</h2>
<div class="lb-trans"><h2>HCA Healthcare 股票表现</h2>
</div><ul>
<li>This ETF Is Proof That the Healthcare Rebound Is Real</li>
</ul>
<div class="lb-trans"><ul>
<li>该 ETF 证明医疗保健反弹是真实的</li>
</ul>
</div><p>NYSE HCA traded down $17.02 during trading on Tuesday, reaching $405.77. The company's stock had a trading volume of 245,089 shares, compared to its average volume of 1,122,558. HCA Healthcare has a twelve month low of $330.00 and a twelve month high of $556.52. The firm has a market cap of $90.02 billion, a price-to-earnings ratio of 14.04, a P/E/G ratio of 1.34 and a beta of 1.18. The business's fifty day moving average price is $476.49 and its 200-day moving average price is $485.66.</p>
<div class="lb-trans"><p>周二，纽约证券交易所 HCA 的交易价格下跌 17.02 美元，达到 405.77 美元。该公司的股票交易量为 245,089 股，而其平均交易量为 1,122,558 股。HCA Healthcare 的十二个月低点为 330.00 美元，十二个月高点为 556.52 美元。该公司的市值为 900.2 亿美元，市盈率为 14.04，市盈率/增长比率为 1.34，贝塔值为 1.18。该公司的 50 日移动平均价格为 476.49 美元，200 日移动平均价格为 485.66 美元。</p>
</div><p>HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). The company had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business's revenue was up 4.3% on a year-over-year basis. During the same quarter last year, the firm earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts forecast that HCA Healthcare will post 30.07 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>HCA Healthcare（纽约证券交易所代码：HCA - 获取免费报告）最近在 4 月 24 日发布了季度财报。该公司报告每股收益（EPS）为 7.15 美元，低于共识预期的 7.19 美元（差额为 0.04 美元）。该公司在本季度的收入为 191.1 亿美元，而分析师预期为 190.9 亿美元。HCA Healthcare 的净利润率为 8.89%，股本回报率为负 295.93%。该公司的收入同比增长 4.3%。去年同期，该公司每股收益为 6.45 美元。HCA Healthcare 已将其 2026 财年的指导目标设定为 29.100-31.500 美元每股收益。作为一个整体，卖方分析师预测 HCA Healthcare 在当前财年将发布 30.07 美元每股收益。</p>
</div><h2>Insider Buying and Selling at HCA Healthcare</h2>
<div class="lb-trans"><h2>HCA Healthcare 的内部买卖</h2>
</div><ul>
<li>MarketBeat Week in Review – 07/28 - 08/01</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周报 – 07/28 - 08/01</li>
</ul>
</div><p>In related news, EVP Michael R. Mcalevey sold 1,694 shares of the company's stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total value of $903,528.78. Following the sale, the executive vice president owned 8,853 shares of the company's stock, valued at approximately $4,721,924.61. This represents a 16.06% decrease in their position. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which can be accessed through this hyperlink. 1.50% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在相关消息中，执行副总裁 Michael R. Mcalevey 在 2 月 18 日的交易中出售了 1,694 股公司的股票。该股票以平均价格 533.37 美元出售，总价值为 903,528.78 美元。出售后，该执行副总裁持有 8,853 股公司的股票，价值约为 4,721,924.61 美元。这代表其持股减少了 16.06%。该交易已在证券交易委员会的备案中披露，可以通过此链接访问。公司内部人士目前持有 1.50% 的股票。</p>
</div><h2>Institutional Trading of HCA Healthcare</h2>
<div class="lb-trans"><h2>HCA Healthcare 的机构交易</h2>
</div><p>Large investors have recently made changes to their positions in the stock. National Pension Service increased its stake in HCA Healthcare by 2.9% in the third quarter. National Pension Service now owns 626,585 shares of the company's stock valued at $267,051,000 after purchasing an additional 17,531 shares during the last quarter. Savant Capital LLC increased its stake in shares of HCA Healthcare by 37.7% during the 3rd quarter. Savant Capital LLC now owns 4,548 shares of the company's stock valued at $1,938,000 after acquiring an additional 1,246 shares during the last quarter. Sector Gamma AS boosted its position in shares of HCA Healthcare by 36.0% in the third quarter. Sector Gamma AS now owns 10,883 shares of the company's stock worth $4,638,000 after acquiring an additional 2,883 shares during the last quarter. Nordea Investment Management AB increased its position in HCA Healthcare by 11.2% during the fourth quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company's stock worth $507,393,000 after purchasing an additional 108,849 shares during the last quarter. Finally, AlphaQuest LLC boosted its holdings in shares of HCA Healthcare by 2,855.2% in the 3rd quarter. AlphaQuest LLC now owns 5,999 shares of the company's stock valued at $2,557,000 after purchasing an additional 5,796 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.</p>
<div class="lb-trans"><p>大型投资者最近对该股票的持仓进行了调整。国家养老服务在第三季度将其在 HCA Healthcare 的股份增加了 2.9%。国家养老服务目前持有 626,585 股公司股票，价值为 267,051,000 美元，此前在上个季度购买了 17,531 股。Savant Capital LLC 在第三季度将其在 HCA Healthcare 的股份增加了 37.7%。Savant Capital LLC 目前持有 4,548 股公司股票，价值为 1,938,000 美元，此前在上个季度增加了 1,246 股。Sector Gamma AS 在第三季度将其在 HCA Healthcare 的持仓增加了 36.0%。Sector Gamma AS 目前持有 10,883 股公司股票，价值为 4,638,000 美元，此前在上个季度增加了 2,883 股。Nordea Investment Management AB 在第四季度将其在 HCA Healthcare 的持仓增加了 11.2%。Nordea Investment Management AB 目前持有 1,084,590 股公司股票，价值为 507,393,000 美元，此前在上个季度购买了 108,849 股。最后，AlphaQuest LLC 在第三季度将其在 HCA Healthcare 的持仓增加了 2,855.2%。AlphaQuest LLC 目前持有 5,999 股公司股票，价值为 2,557,000 美元，此前在上个季度增加了 5,796 股。机构投资者和对冲基金持有该公司 62.73% 的股票。</p>
</div><h2>About HCA Healthcare</h2>
<div class="lb-trans"><h2>关于 HCA Healthcare</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.</p>
<div class="lb-trans"><p>HCA Healthcare 是一家以盈利为目的的医疗设施运营商，总部位于田纳西州纳什维尔。该公司成立于 1968 年，拥有并运营一系列医院和相关医疗设施，并通过有机扩展和收购成长为大型住院和门诊服务提供商。</p>
</div><p>The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.</p>
<div class="lb-trans"><p>该公司的核心业务包括急性护理医院、独立外科和急救中心以及门诊诊所的运营。HCA 的服务涵盖住院护理、外科服务、急救医学、诊断影像和实验室检测，以及各种门诊和流动护理服务。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than HCA Healthcare</li>
<li>Rewiring AI: NextEra Energy Sparks a Mega Merger</li>
<li>Flipping the Switch: Is Ford the Next Big Energy Stock?</li>
<li>Does Nano Nuclear Energy’s New Deal Amp the Outlook?</li>
<li>3 Dividend Stocks With Insiders Buying in 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 HCA Healthcare 更好</li>
<li>重塑人工智能：NextEra Energy 引发了一场巨型合并</li>
<li>切换开关：福特会是下一个大能源股票吗？</li>
<li>纳米核能的新交易是否提升了前景？</li>
<li>3 只内部人士在 2026 年买入的股息股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=HCA"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in HCA Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 HCA Healthcare 吗？</h2>
</div><p>Before you consider HCA Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 HCA Healthcare 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 HCA Healthcare 并不在名单上。</p>
</div><p>While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 HCA Healthcare 目前在分析师中有中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

HCA Healthcare (NYSE:HCA) Price Target Cut to $490.00 by Analysts at JPMorgan Chase & Co.

Market Beat

摩根大通

高盛

科凯国际

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

GS Hldg R

KEYCORP DEP SHS REP 1/40TH NON CUM PER PFD SER G

KEYCORP DEP SHS REPSTG 1/40TH INT PERP NON CUM H

KEYCORP DEP SHS REP 1/40TH PERP PFD SER F USD25

KEYCORP DEP SHS REP 1/40TH NON CUM PFD SER E

摩根大通的分析师将 HCA Healthcare（NYSE:HCA）的目标股价下调至 490.00 美元